Concepedia

Bo Yin

BY

23

Publications

865

Citations

19

H-Index

2011

Active since

Affiliations

China Medical University(Current)

First Hospital of China Medical University

Johns Hopkins Medicine

Johns Hopkins University

Shanghai First Maternity and Infant Hospital

Bo Yin is an author at China Medical University specializing in medicine, tumor microenvironment, and cell biology.

ORCID

Top concepts

Publications per year

2011–2025

23

Publications

23

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer

Ming Chi, Jiao Liu, Chenxue Mei et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 148 citations · Full text

Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells

Yanju Wu, Qianqian Zheng, Yan Li et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 101 citations · Full text

EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression

Meiqin Yang, Haoran Hu, Sufang Wu et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 95 citations · Full text

Acquisition of paclitaxel resistance is associated with a more aggressive and invasive phenotype in prostate cancer

John J. Kim, Bo Yin, Christhunesa S. Christudass et al. · Journal of Cellular Biochemistry · 2012 · 66 citations · Full text

Creatine kinase brain overexpression protects colorectal cells from various metabolic and non‐metabolic stresses

Steven M. Mooney, Krithika Rajagopalan, Brenten H. Williams et al. · Journal of Cellular Biochemistry · 2011 · 49 citations · Full text

, , +25

Rows per page

1–5 of 23